92 related articles for article (PubMed ID: 15678881)
61. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
62. [Correlation between 21st century COE of Center for Frontier Research Education on Lifestyle-Related Disease based on the large-scale cohort study and Kyushu University Hospital].
Nawata H
Fukuoka Igaku Zasshi; 2004 Oct; 95(10):253. PubMed ID: 15678881
[No Abstract] [Full Text] [Related]
63. Genomics and proteomics methodologies for vulnerable populations research.
Kasper CE
Annu Rev Nurs Res; 2007; 25():191-217. PubMed ID: 17958293
[TBL] [Abstract][Full Text] [Related]
64. [Search for type 2 diabetes susceptibility genes].
Hirota Y; Kasuga M
Tanpakushitsu Kakusan Koso; 2005 Dec; 50(16 Suppl):2084-9. PubMed ID: 16411434
[No Abstract] [Full Text] [Related]
65. [BioBank Japan project].
Ohnishi Y; Nakamura Y
Nihon Rinsho; 2005 Dec; 63 Suppl 12():35-41. PubMed ID: 16416768
[No Abstract] [Full Text] [Related]
66. Pharmacogenetics of osteoporosis and the prospect of individualized prognosis and individualized therapy.
Nguyen TV; Center JR; Eisman JA
Curr Opin Endocrinol Diabetes Obes; 2008 Dec; 15(6):481-8. PubMed ID: 18971675
[TBL] [Abstract][Full Text] [Related]
67. What will whole genome searches for susceptibility genes for common complex disease offer to clinical practice?
Lango H; Weedon MN
J Intern Med; 2008 Jan; 263(1):16-27. PubMed ID: 18088250
[TBL] [Abstract][Full Text] [Related]
68. [Secular trends and current status of lifestyle-related diseases: the Hisayama Study].
Kiyohara Y
Fukuoka Igaku Zasshi; 2006 Aug; 97(8):231-9. PubMed ID: 17087360
[No Abstract] [Full Text] [Related]
69. Recent development in pharmacogenomics: from candidate genes to genome-wide association studies.
Grant SF; Hakonarson H
Expert Rev Mol Diagn; 2007 Jul; 7(4):371-93. PubMed ID: 17620046
[TBL] [Abstract][Full Text] [Related]
70. Will investments in biobanks, prospective cohorts, and markers of common patterns of variation benefit other populations for drug response and disease susceptibility gene discovery?
Foster MW; Sharp RR
Pharmacogenomics J; 2005; 5(2):75-80. PubMed ID: 15668730
[No Abstract] [Full Text] [Related]
71. Metabolism, lifestyle and bipolar affective disorder.
Morriss R; Mohammed FA
J Psychopharmacol; 2005 Nov; 19(6 Suppl):94-101. PubMed ID: 16280342
[TBL] [Abstract][Full Text] [Related]
72. [To know is to relieve; "lifestyle-related diseases"; as they are now and how to prevent them].
Yoshioka N; Yoshioka M; Furuta Y; Asaka M
Hokkaido Igaku Zasshi; 2006 Mar; 81(2):95-9. PubMed ID: 16607881
[TBL] [Abstract][Full Text] [Related]
73. [Obesity as a cause and result of disability].
Piechota G; Małkiewicz J; Karwat ID
Przegl Epidemiol; 2005; 59(1):155-61. PubMed ID: 16013421
[TBL] [Abstract][Full Text] [Related]
74. [Personalized medicine: current status].
Tsujimoto G
Arerugi; 2004 Oct; 53(10):1062-5. PubMed ID: 15672724
[No Abstract] [Full Text] [Related]
75. The gene for human IL-21 and genetic susceptibility to type 1 diabetes in the Japanese.
Asano K; Ikegami H; Fujisawa T; Kawabata Y; Noso S; Hiromine Y; Ogihara T
Ann N Y Acad Sci; 2006 Oct; 1079():47-50. PubMed ID: 17130531
[TBL] [Abstract][Full Text] [Related]
76.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
